ALTG 13/003 Rekindle: testing an online resource to promote sexual wellbeing for both patients and their partners – H Dhillon

Studies have estimated that between 40-100% of cancer survivors experience negative sexual changes after treatment. Changes to sexuality can lead to psychological and emotional distress for not only survivors, but also their partners, impacting their long-term quality of life.  Rekindle is a phase 2 study developed at The University of Sydney in partnership with Cancer Council New South Wales and funding from Australian Research Council.

The program tested the feasibility of recruiting participants into an online resource to deliver therapy intended to address concerns about sexuality in both patients and partners after a cancer diagnosis. The Rekindle trial closed to recruitment in November 2016 with 101 participants.  The final participants are completing their 6 month follow-up assessment, all are due to finish by mid-May 2017.  The main study analyses are in progress and our indepth interviews with participants are also being analysed to provide detailed process data about the trial and the intervention.  Stay posted for a series of manuscripts over the coming months.

For information or to request materials, contact Dr. Haryana Dhillon, Principal Investigator, at haryana.dhillon@sydney.edu.au

Upcoming Events
  1. 4th ALTG Preceptorship in Lung Cancer, Melbourne, VIC

    August 17 - August 18
  2. Management Advisory Committee (MAC) Meeting

    August 31
  3. Scientific Advisory Committee (SAC) Meeting

    August 31
  4. 2018 ALTG Speaking Tour – Melbourne evening

    October 2 @ 6:00 pm - 9:00 pm
  5. 2018 ALTG Speaking Tour – Brisbane evening

    October 4 @ 6:00 pm - 9:00 pm